2023-11-14 07:33:51 ET
DENVER, Colo., Nov 14, 2023 ( www.247marketnews.com )- INVO Bioscience, Inc. (NASDAQ: INVO) reported, after yesterday’s market close, its third quarter financial results and stated that it expects to host a call concerning its NAYA definitive merger agreement, after November 20th. Its revenues increased 314%, from $235,321 to $974,894 and, assuming a full quarter of the recently acquired Wisconsin Fertility Institute, pro forma revenue for Q3 2023 would have been approximately $1.5 million.
INVO Bioscience is trading at $2.11, up $0.50 (+31.1%) on 990.4K premarket shares.
Its 52-week range is $0.50 to $25.398. It’s positioned to challenge its October 23 trading levels.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of …
The post INVO Hits Record Q3 2023 Financial Results appeared first on 24/7 Market News .
For further details see:
INVO Hits Record Q3 2023 Financial Results